The independent source for health policy research, polling, and news.
1,961-1,980 of 3,999 results
As the rural town of Fort Scott, Kan., grapples with the closure of its hospital, cancer patients face new challenges as they try to continue their treatments in different locations.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
A draft plan spearheaded by House Speaker Nancy Pelosi would allow the federal government for the first time to negotiate prices for 250 drugs for Medicare and apply those prices to all payers, including employers and insurers.
At the first Democratic presidential primary debate, former U.S. lawmaker John Delaney outlined his opposition to “Medicare for All” by claiming it would prove fatal for hospitals. It’s really not that simple.
Democratic presidential candidates disagreed on how to fix health care in their first debate Wednesday, although they all called for boosting insurance coverage and lowering prices. Meanwhile, the Trump administration is keeping health care in the news, too, with a new plan to make medical prices more available to the public. Stephanie Armour of The Wall Street Journal, Rebecca Adams of CQ Roll Call and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss this, plus the latest in news about bipartisan progress on catch-all legislation to address “surprise” medical bills. Plus, Rovner interviews NPR’s Jon Hamilton about the latest KHN-NPR “Bill of the Month” installment.
On the first of the Democrat’s two-night debate, only New York City Mayor Bill de Blasio and Massachusetts Sen. Elizabeth Warren offered full support for a single-payer system that would banish private health insurance.
The measure also includes a range of provisions designed to address health care costs.
Guess who’s back grabbing headlines? Pharmacy benefit managers — those companies that serve as middlemen in the prescription drug pipeline.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
A new data analysis by KHN and Johns Hopkins researchers shows that even as the CDC issued warnings, surgeons handed out many times the number of opioid pills needed for post-op pain.
Even as awareness of the opioid crisis grew, prescribing habits of surgeons changed very little from 2011 to 2016, found a data analysis by KHN and Johns Hopkins Bloomberg School of Public Health. Use this interactive tool to search by doctor or practicing hospital.
A legislative package from Sens. Lamar Alexander (R-Tenn.) and Patty Murray (D-Wash.) would handle surprise medical bills by having insurers pay them the “median in-network rate,” meaning the rate would be similar to what the plan charges other doctors in the area for the same procedure.
The Senate Health, Education, Labor and Pensions Committee is scheduled next week to mark up a massive legislative package on curbing health costs, but some of the details remain unresolved, including what formula to use to pay doctors and hospitals involved in surprise medical bills.
The use of ECMO, the most aggressive form of life support in modern medicine, has skyrocketed — but along with miraculous rescues, it can leave patients in limbo, kept alive with machines but with no prospect of survival outside the ICU.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
The median cost of an air ambulance bill is more than $36,000 and seldom covered by insurance, sparking many consumer complaints. Yet none of the proposals introduced or circulating in Congress to fix surprise medical bills address these services.
Supporters of the rule say it would strengthen health care professionals’ freedom of conscience, but opponents say it “empowers bad actors to be bad actors.”
In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
The scientific use of tissue from aborted fetuses has frequently been a hot point of contention between anti-abortion forces and researchers. It heats up again as federal officials announced this week they were ending NIH research using the tissue.
© 2026 KFF